CLYM Climb Bio, Inc. logo

CLYM Climb Bio, Inc.

Healthcare
$11.00+0.82%ClosedMarket Cap: $750.0M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

1

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+2,106,000

Shares Acquired

2,106,000

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed Apr 29RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Sell2,106,000$0.0022,546,000
Fri Feb 27Thomas Stephen BasildirectorSell33,687$7.00170,970
Fri Feb 27Thomas Stephen BasildirectorSell16,313$7.01154,657
Tue Feb 17Thomas Stephen BasildirectorSell90,000$5.23214,657
Tue Feb 17Thomas Stephen BasildirectorSell10,000$5.81204,657
Thu Jan 08Wilson Perrin Meganofficer: Chief Business OfficerSell300,000$3.81300,000
Thu Jan 08Driscoll Cindyofficer: Senior Vice President, FinanceSell100,000$3.81100,000
Thu Jan 08Brennan Aoifedirector, officer: President and CEOSell700,000$3.81700,000
Thu Jan 08ALTSCHULLER Susanofficer: Chief Financial OfficerSell142,500$3.81142,500
Wed Jan 07RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Buy7,111$3.503,403,429
Mon Dec 15RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Sell20,440,000$0.0020,440,000